Buy Glucophage SR

Glucophage SR

Glucophage SR: What Is It?

Glucophage SR is a brand-name medication that contains metformin as its active ingredient. Metformin belongs to the biguanide class of oral antidiabetic drugs and is used to improve blood-sugar control in adults with type 2 diabetes. Glucophage SR is supplied as a 500 mg sustained-release (SR) pill and is available only with a prescription in the United Kingdom. The Medicines and Healthcare products Regulatory Agency (MHRA) classifies it as a prescription-only medicine (POM).

How Glucophage SR Works in the Body

Metformin lowers blood glucose through several complementary actions:

• Reduced hepatic glucose production - it inhibits the enzyme gluconeogenesis in the liver, decreasing the amount of glucose released into the bloodstream.
• Improved peripheral insulin sensitivity - muscle and fat cells take up glucose more efficiently, partly by increasing the activity of the insulin-stimulated glucose transporter 4 (GLUT-4).
• Modest effect on intestinal glucose absorption - metformin slows the uptake of glucose from the gut after meals.

These mechanisms together help keep fasting and post-prandial blood-sugar levels within target ranges, without stimulating insulin release. The sustained-release formulation provides a steadier plasma concentration, which reduces gastrointestinal irritation compared with immediate-release tablets.

Conditions Treated by Glucophage SR

Glucophage SR is approved by the MHRA for the following indications:

• Type 2 diabetes mellitus in adults, as part of a comprehensive management plan that includes diet, exercise, and, when needed, additional glucose-lowering agents.

It is not indicated for type 1 diabetes, gestational diabetes, or for managing high blood pressure.

Off-Label and Investigational Applications

Current peer-reviewed evidence supports the use of metformin for a limited set of off-label conditions, but these uses are not approved by the MHRA and should only be pursued under specialist supervision:

• Polycystic ovary syndrome (PCOS) - metformin can improve menstrual regularity and insulin resistance in some women with PCOS.
• Prediabetes - metformin may delay progression to overt diabetes in high-risk individuals, as demonstrated in the Diabetes Prevention Program trial.

Off-label use requires medical supervision and individualized risk assessment.

Who Should (Not) Use Glucophage SR?

Ideal Patient Profile

• Adults diagnosed with type 2 diabetes who require an oral medication to lower blood glucose.
• Individuals who can tolerate metformin’s gastrointestinal profile or who benefit from the sustained-release formulation’s reduced side-effects.

Absolute Contraindications

• Known hypersensitivity to metformin or any component of the tablet.
• Severe renal impairment (eGFR < 30 mL/min/1.73 m²).
• Significant hepatic dysfunction.
• Acute or chronic metabolic acidosis, including diabetic ketoacidosis.
• Pregnancy - metformin is not recommended as a first-line therapy for gestational diabetes without specialist advice.

Relative Contraindications

• Moderate renal impairment (eGFR 30-45 mL/min/1.73 m²) - dose reduction and close monitoring are required.
• Older adults (≥ 75 years) - may need lower starting doses and slower titration.
• Concurrent use of iodinated contrast agents - temporary discontinuation of metformin is advised to reduce the risk of lactic acidosis.

Special Populations

• Lactation: Metformin passes into breast milk in small amounts; continuation is generally considered safe, but clinical judgment is required.
• Patients with hepatic disease: Use only if liver function is stable and monitored.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Gastro-intestinal upset (nausea, abdominal discomfort, diarrhea) - reported in up to 30 % of users, usually mild and transient.
• Metallic taste - occasional, resolves with continued therapy.
• Weight stabilization or modest loss - often noted by patients using metformin.

Serious Adverse Events

• Lactic acidosis - a rare but potentially fatal condition; risk increases with renal impairment, severe infection, or hypoxia. Immediate medical attention is required if patients experience rapid breathing, muscle pain, or unexplained fatigue.
• Vitamin B12 deficiency - long-term metformin use can reduce absorption of vitamin B12; periodic monitoring is advisable.

Drug Interactions

• Cimetidine, ranitidine, nifedipine - can increase metformin plasma concentrations; dose adjustment may be needed.
• Contrast media (iodinated) - may precipitate acute renal dysfunction; withhold metformin for 48 hours after imaging and resume only after renal function is confirmed normal.
• Alcohol - potentiates the risk of lactic acidosis; patients should limit intake.

Food and Lifestyle Interactions

• Take with meals - the SR formulation should be swallowed whole with food to reduce gastrointestinal irritation and improve absorption.
• Alcohol consumption - excessive intake should be avoided.
• Driving and machinery - metformin does not impair cognition; however, severe hypoglycaemia (rare with metformin alone) could affect performance, so patients should monitor symptoms.

How to Take Glucophage SR

• Standard dosing: Begin with one 500 mg tablet taken with the evening meal. The dose may be increased by 500 mg weekly, based on glycaemic response, up to a typical maximum of 2000 mg per day (four tablets), divided into two doses if needed.
• Renal adjustment: For eGFR 30-45 mL/min/1.73 m², start with 500 mg once daily and avoid exceeding 1000 mg per day.
• Administration: Swallow the tablet whole; do not crush or chew, as this defeats the sustained-release design.
• Missed dose: Take the missed tablet as soon as remembered if it is still within a reasonable time before the next scheduled dose; otherwise skip it and continue the regular schedule. Do not double the dose.
• Overdose: Early symptoms may include nausea, vomiting, abdominal pain, and lethargy. Seek emergency medical care; dialysis can accelerate removal of metformin in severe cases.
• Discontinuation: If stopping abruptly, no taper is required, but patients should be monitored for rebound hyperglycaemia.

Monitoring and Follow-Up

• Renal function: Check serum creatinine and eGFR at baseline, then at least annually, or more frequently if renal disease is present.
• Glycaemic control: HbA1c should be measured every 3-6 months to assess treatment efficacy.
• Vitamin B12: Consider checking levels every 2-3 years in long-term users.
• Lactic acidosis warning signs: Educate patients to report sudden breathlessness, muscle pain, or unexplained fatigue promptly.

Storage and Handling

• Store tablets at controlled room temperature (15-25 °C), protected from moisture and direct sunlight.
• Keep the container tightly closed and out of reach of children.
• Do not use tablets after the printed expiry date.
• Dispose of unused medication via a pharmacist-led take-back scheme or according to local NHS guidelines.

Glossary (Medication-Specific)

Sustained-Release (SR)

A formulation that releases the active drug slowly over several hours, providing more stable blood concentrations and often reducing side-effects.

Lactic Acidosis

A rare metabolic emergency characterised by the accumulation of lactic acid in the blood, potentially fatal if untreated; associated with metformin in the context of renal insufficiency or hypoxia.

Therapeutic Window

The range of drug concentrations in which Metformin is effective without causing unacceptable toxicity.

Medical Disclaimer

This article provides educational information about Glucophage SR and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.